FDA will drop two-study requirement for new drug approvals, aiming to speed access The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals.

This rule contrasts with the #FDA’s more restrictive approach to other products, including #vaccines. #RxApprovals #Rx #PublicHealth